Positive effects have also been confirmed in vivo as osmotin through activation of the AdipoR1/2, APPL1, AMPK pathway, reduced blood glucose levels, decreased insulin resistance, and increased fatty acid oxidation and mitochondrial function (Ahmad et al., 2019). The gene discussed is ADIPOR1; the disease is Insulin resistance.